Radiotherapy followed by adjuvant temozolomide with or without neoadjuvant ACNU-CDDP chemotherapy in newly diagnosed glioblastomas: a prospective randomized controlled multicenter phase III trial

Il Han Kim; Chul-Kee Park; Dae Seog Heo; Chae-Yong Kim; Chang Hun Rhee; Do-Hyun Nam; Seung Hoon Lee; Jung Ho Han; Se-Hoon Lee; Tae Min Kim; Dong-Wan Kim; Jeong Eun Kim; Sun Ha Paek; Dong Gyu Kim; In Ah Kim; Yu Jung Kim; Jee Hyun Kim; Byung-Joo Park; Hee-Won Jung

doi:10.1007/s11060-010-0427-y

Radiotherapy followed by adjuvant temozolomide with or without neoadjuvant ACNU-CDDP chemotherapy in newly diagnosed glioblastomas: a prospective randomized controlled multicenter phase III trial

Journal of Neuro-Oncology ◽

10.1007/s11060-010-0427-y ◽

2010 ◽

Vol 103 (3) ◽

pp. 595-602 ◽

Cited By ~ 21

Author(s):

Il Han Kim ◽

Chul-Kee Park ◽

Dae Seog Heo ◽

Chae-Yong Kim ◽

Chang Hun Rhee ◽

...

Keyword(s):

Phase Iii ◽

Newly Diagnosed ◽

Phase Iii Trial ◽

Randomized Controlled ◽

Multicenter Phase ◽

Adjuvant Temozolomide

Download Full-text

OC-0333 Dose-painting multicenter phase III trial in newly diagnosed glioblastoma: the SPECTRO-GLIO trial

Radiotherapy and Oncology ◽

10.1016/s0167-8140(21)06866-3 ◽

2021 ◽

Vol 161 ◽

pp. S246-S247

Author(s):

A. Laprie ◽

G. Noel ◽

L. Chaltiel ◽

G. Truc ◽

M. Sunyach ◽

...

Keyword(s):

Phase Iii ◽

Newly Diagnosed ◽

Dose Painting ◽

Phase Iii Trial ◽

Multicenter Phase ◽

Newly Diagnosed Glioblastoma

Download Full-text

ESOPEC: A prospective randomized controlled multicenter phase III trial comparing perioperative chemotherapy to neoadjuvant chemoradiation in patients with adenocarcinoma of the esophagus (NCT02509286).

Journal of Clinical Oncology ◽

10.1200/jco.2016.34.15_suppl.tps4131 ◽

2016 ◽

Vol 34 (15_suppl) ◽

pp. TPS4131-TPS4131

Author(s):

Jens Hoeppner ◽

Florian Lordick ◽

Thomas B. Brunner ◽

Torben Glatz ◽

Claudia Schmoor ◽

...

Keyword(s):

Neoadjuvant Chemoradiation ◽

Phase Iii ◽

Perioperative Chemotherapy ◽

Adenocarcinoma Of The Esophagus ◽

Phase Iii Trial ◽

Randomized Controlled ◽

Multicenter Phase

Download Full-text

Randomized, Controlled, Multicenter Phase III Trial of Standard-Dose Fluorouracil-Epirubicin- Cyclophosphamide (FEC), Compared with Time-Intensive FEC (FEC-G) and Mitoxantrone-Methotrexate-Mitomycin C (MMM-G) in Metastatic Breast Carcinoma

Journal of Chemotherapy ◽

10.1179/joc.2003.15.2.184 ◽

2003 ◽

Vol 15 (2) ◽

pp. 184-191 ◽

Cited By ~ 12

Author(s):

A.M. Capotorto ◽

L. Pavesi ◽

P. Pedrazzoli ◽

G.A. Da Prada ◽

C. Zamagni ◽

...

Keyword(s):

Breast Carcinoma ◽

Mitomycin C ◽

Standard Dose ◽

Metastatic Breast ◽

Phase Iii ◽

Phase Iii Trial ◽

Metastatic Breast Carcinoma ◽

Randomized Controlled ◽

Multicenter Phase

Download Full-text

ESOPEC: prospective randomized controlled multicenter phase III trial comparing perioperative chemotherapy (FLOT protocol) to neoadjuvant chemoradiation (CROSS protocol) in patients with adenocarcinoma of the esophagus (NCT02509286)

BMC Cancer ◽

10.1186/s12885-016-2564-y ◽

2016 ◽

Vol 16 (1) ◽

Cited By ~ 77

Author(s):

Jens Hoeppner ◽

Florian Lordick ◽

Thomas Brunner ◽

Torben Glatz ◽

Peter Bronsert ◽

...

Keyword(s):

Neoadjuvant Chemoradiation ◽

Phase Iii ◽

Perioperative Chemotherapy ◽

Adenocarcinoma Of The Esophagus ◽

Phase Iii Trial ◽

Randomized Controlled ◽

Multicenter Phase

Download Full-text

RTOG 0525: A randomized phase III trial comparing standard adjuvant temozolomide (TMZ) with a dose-dense (dd) schedule in newly diagnosed glioblastoma (GBM).

Journal of Clinical Oncology ◽

10.1200/jco.2011.29.15_suppl.2006 ◽

2011 ◽

Vol 29 (15_suppl) ◽

pp. 2006-2006 ◽

Cited By ~ 45

Author(s):

M. R. Gilbert ◽

M. Wang ◽

K. D. Aldape ◽

R. Stupp ◽

M. Hegi ◽

...

Keyword(s):

Phase Iii ◽

Newly Diagnosed ◽

Phase Iii Trial ◽

Adjuvant Temozolomide ◽

Newly Diagnosed Glioblastoma ◽

Dose Dense

Download Full-text

Results of a Randomized Controlled Multicenter Phase III Trial of Percutaneous Hepatic Perfusion Compared with Best Available Care for Patients with Melanoma Liver Metastases

Annals of Surgical Oncology ◽

10.1245/s10434-015-4968-3 ◽

2015 ◽

Vol 23 (4) ◽

pp. 1309-1319 ◽

Cited By ~ 61

Author(s):

Marybeth S. Hughes ◽

Jonathan Zager ◽

Mark Faries ◽

H. Richard Alexander ◽

Richard E. Royal ◽

...

Keyword(s):

Liver Metastases ◽

Phase Iii ◽

Phase Iii Trial ◽

Hepatic Perfusion ◽

Randomized Controlled ◽

Multicenter Phase ◽

Percutaneous Hepatic Perfusion

Download Full-text

PO-0957 Radiomics study from the dose-painting multicenter phase III trial on newly diagnosed glioblastoma

Radiotherapy and Oncology ◽

10.1016/s0167-8140(19)31377-5 ◽

2019 ◽

Vol 133 ◽

pp. S518-S519

Author(s):

F. Tensaouti ◽

J. Bailleul ◽

E. Martin ◽

F. Desmoulin ◽

S. Ken ◽

...

Keyword(s):

Phase Iii ◽

Newly Diagnosed ◽

Dose Painting ◽

Phase Iii Trial ◽

Multicenter Phase ◽

Newly Diagnosed Glioblastoma

Download Full-text

Concomitant and adjuvant temozolomide (TMZ) and radiotherapy (RT) for newly diagnosed glioblastoma multiforme (GBM). Conclusive results of a randomized phase III trial by the EORTC

Neurochirurgie ◽

10.1016/s0028-3770(05)83425-3 ◽

2005 ◽

Vol 51 (1) ◽

pp. 50 ◽

Cited By ~ 1

Author(s):

R. Stupp ◽

W.P. Mason ◽

M.J. Van Den Bent ◽

M. Weller ◽

B. Fisher ◽

...

Keyword(s):

Glioblastoma Multiforme ◽

Phase Iii ◽

Newly Diagnosed ◽

Phase Iii Trial ◽

Adjuvant Temozolomide ◽

Newly Diagnosed Glioblastoma

Download Full-text

Dose-painting multicenter phase III trial in newly diagnosed glioblastoma: the SPECTRO-GLIO trial comparing arm A standard radiochemotherapy to arm B radiochemotherapy with simultaneous integrated boost guided by MR spectroscopic imaging

BMC Cancer ◽

10.1186/s12885-019-5317-x ◽

2019 ◽

Vol 19 (1) ◽

Cited By ~ 8

Author(s):

Anne Laprie ◽

Soléakhéna Ken ◽

Thomas Filleron ◽

Vincent Lubrano ◽

Laure Vieillevigne ◽

...

Keyword(s):

Spectroscopic Imaging ◽

Simultaneous Integrated Boost ◽

Phase Iii ◽

Newly Diagnosed ◽

Dose Painting ◽

Phase Iii Trial ◽

Multicenter Phase ◽

Integrated Boost ◽

Newly Diagnosed Glioblastoma ◽

Mr Spectroscopic Imaging

Download Full-text

Concomitant and adjuvant temozolomide (TMZ) and radiotherapy (RT) for newly diagnosed glioblastoma multiforme (GBM). Conclusive results of a randomized phase III trial by the EORTC Brain & RT Groups and NCIC Clinical Trials Group

Journal of Clinical Oncology ◽

10.1200/jco.2004.22.14_suppl.2 ◽

2004 ◽

Vol 22 (14_suppl) ◽

pp. 2-2 ◽

Cited By ~ 32

Author(s):

R. Stupp ◽

W. P. Mason ◽

M. J. Van Den Bent ◽

M. Weller ◽

B. Fisher ◽

...

Keyword(s):

Clinical Trials ◽

Glioblastoma Multiforme ◽

Phase Iii ◽

Newly Diagnosed ◽

Phase Iii Trial ◽

Adjuvant Temozolomide ◽

Newly Diagnosed Glioblastoma

Download Full-text